Non-steroidal glucocorticoid receptor antagonists: the race to replace RU-486 for anti-glucocorticoid therapy.

about

Selective androgen receptor modulators in preclinical and clinical development Effects of selective and non-selective glucocorticoid receptor II antagonists on rapid-onset diabetes in young rats Recent advances in the development of novel glucocorticoid receptor modulators.

P2860

Q24645579-E3EA7F20-D9FA-4F68-A781-EC3B3C85596C Q28541028-2031BE2E-EA80-4B5A-94CA-8C0937FEE522 Q37765564-263CB319-7B04-45BF-BA8D-0A24B2CAD5EA

P2860

Non-steroidal glucocorticoid receptor antagonists: the race to replace RU-486 for anti-glucocorticoid therapy.

Item

http://www.wikidata.org/entity/Q43167314

description

2007 nî lūn-bûn

@nan

2007年の論文

@ja

2007年学术文章

@wuu

2007年学术文章

@zh

2007年学术文章

@zh-cn

2007年学术文章

@zh-hans

2007年学术文章

@zh-my

2007年学术文章

@zh-sg

2007年學術文章

@yue

2007年學術文章

@zh-hant

name

Non-steroidal glucocorticoid r ...... r anti-glucocorticoid therapy.

@en

Non-steroidal glucocorticoid r ...... r anti-glucocorticoid therapy.

@nl

type

Item

label

Non-steroidal glucocorticoid r ...... r anti-glucocorticoid therapy.

@en

Non-steroidal glucocorticoid r ...... r anti-glucocorticoid therapy.

@nl

prefLabel

Non-steroidal glucocorticoid r ...... r anti-glucocorticoid therapy.

@en

Non-steroidal glucocorticoid r ...... r anti-glucocorticoid therapy.

@nl

P1476

Non-steroidal glucocorticoid r ...... r anti-glucocorticoid therapy.

@en

P2093

Duane D Miller

http://www.w3.org/2001/XMLSchema#string

Michael L Mohler

http://www.w3.org/2001/XMLSchema#string

Seoung-Soo Hong

http://www.w3.org/2001/XMLSchema#string

Yali He

http://www.w3.org/2001/XMLSchema#string

Zhongzhi Wu

http://www.w3.org/2001/XMLSchema#string

P2860

The three-dimensional structures of antagonistic and agonistic forms of the glucocorticoid receptor ligand-binding domain: RU-486 induces a transconformation that leads to active antagonism

Molecular basis of agonism and antagonism in the oestrogen receptor

Classic and recent etiologies of Cushing's syndrome: diagnosis and therapy.

Therapeutic benefit of a dissociated glucocorticoid and the relevance of in vitro separation of transrepression from transactivation activity.

RU 486: how abortion politics have impacted on a potentially useful drug of broad medical application.

Glucocorticoid receptor antagonism by cyproterone acetate and RU486.

Treatment of depression with antiglucocorticoid drugs.

Design of thyroid hormone receptor antagonists from first principles.

The use of mifepristone in the treatment of neuropsychiatric disorders.

Hepatic nuclear factor 3- and hormone-regulated expression of the phosphoenolpyruvate carboxykinase and insulin-like growth factor-binding protein 1 genes.

P304

59-81

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1517/13543776.17.1.59

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2007-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

20144063

http://www.w3.org/2001/XMLSchema#string

Non-steroidal glucocorticoid receptor antagonists: the race to replace RU-486 for anti-glucocorticoid therapy.

about

P2860

P2860

Non-steroidal glucocorticoid receptor antagonists: the race to replace RU-486 for anti-glucocorticoid therapy.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P698